Emergent Biosolutions Inc. (EBS) vs Lifecore Biomedical, Inc. (LFCR)
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
- Lifecore Biomedical, Inc. LFCR 6.38 −0.93%
Emergent Biosolutions Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $368.1M against $244.1M — 1.5× the size. Emergent Biosolutions Inc. grew revenue faster over the last twelve months: −9.56% against −10.0%. Emergent Biosolutions Inc. has the higher net margin (−23.0% vs −37.5%) and the lower return on invested capital (−5.27% vs −2.80%). Across the 18 metrics below, Emergent Biosolutions Inc. leads on 11 and Lifecore Biomedical, Inc. on 7.
Valuation
Profitability
| Metric | EBS | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.87% | 26.86% | 53.94% |
| Operating margin | (8.57%) | (6.89%) | 0.00% |
| Net margin | (22.96%) | (37.54%) | 0.00% |
| Free cash flow margin | 11.18% | (4.24%) | 0.00% |
| Return on equity | (40.29%) | 201.15% | (0.40%) |
| Return on assets | (13.95%) | (19.32%) | (3.32%) |
| Return on invested capital | (5.27%) | (2.80%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack